Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

New Zealand (NZX) Pharma Industry Analysis

UpdatedAug 20, 2025
DataAggregated Company Financials
Companies3
  • 7D-1.9%
  • 3M3.0%
  • 1Y-15.7%
  • YTD-8.2%

Over the last 7 days, the Pharma industry has dropped 1.9%, driven by AFT Pharmaceuticals declining 0.8%. On the other hand Rua Bioscience is actually up 8.3%. However, the industry is down 16% over the past year. Looking forward, earnings are forecast to grow by 26% annually.

Industry Valuation and Performance

Has the New Zealand Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 20 Aug 2025NZ$306.0mNZ$221.8mNZ$8.1m25.1x37.6x1.4x
Fri, 18 Jul 2025NZ$316.3mNZ$221.8mNZ$8.1m25.6x38.9x1.4x
Sun, 15 Jun 2025NZ$305.5mNZ$221.8mNZ$8.1m23.9x37.6x1.4x
Tue, 13 May 2025NZ$300.4mNZ$212.4mNZ$8.5m18x35.4x1.4x
Thu, 10 Apr 2025NZ$280.9mNZ$212.4mNZ$8.5m16.9x33.1x1.3x
Sat, 08 Mar 2025NZ$299.1mNZ$212.4mNZ$8.5m17.5x35.3x1.4x
Mon, 03 Feb 2025NZ$321.0mNZ$211.6m-NZ$566,754.0018.5x-566.4x1.5x
Wed, 01 Jan 2025NZ$330.7mNZ$211.6m-NZ$566,754.0019.3x-583.5x1.6x
Fri, 29 Nov 2024NZ$324.4mNZ$211.6m-NZ$566,754.0019.8x-572.4x1.5x
Sun, 27 Oct 2024NZ$371.2mNZ$207.3mNZ$2.5m23.9x146.4x1.8x
Tue, 24 Sep 2024NZ$369.4mNZ$207.3mNZ$2.5m31.4x145.6x1.8x
Thu, 22 Aug 2024NZ$361.9mNZ$207.5m-NZ$1,274,813.0028.3x-283.9x1.7x
Sat, 20 Jul 2024NZ$353.7mNZ$207.5m-NZ$1,274,813.0027.1x-277.4x1.7x
Mon, 17 Jun 2024NZ$398.3mNZ$208.5m-NZ$10,082,906.0029.4x-39.5x1.9x
Wed, 15 May 2024NZ$343.1mNZ$186.8m-NZ$15,744,906.0025x-21.8x1.8x
Fri, 12 Apr 2024NZ$408.1mNZ$186.8m-NZ$15,744,906.0031.1x-25.9x2.2x
Sun, 10 Mar 2024NZ$406.3mNZ$186.8m-NZ$15,744,906.0030.2x-25.8x2.2x
Tue, 06 Feb 2024NZ$474.7mNZ$185.9mNZ$4.6m35.5x102.5x2.6x
Thu, 04 Jan 2024NZ$467.3mNZ$185.9mNZ$4.6m34.5x100.8x2.5x
Sat, 02 Dec 2023NZ$446.9mNZ$185.9mNZ$4.6m32.3x96.5x2.4x
Mon, 30 Oct 2023NZ$463.9mNZ$167.6mNZ$3.3m33.5x138.7x2.8x
Wed, 27 Sep 2023NZ$463.0mNZ$167.6mNZ$3.3m32.9x138.4x2.8x
Fri, 25 Aug 2023NZ$499.2mNZ$167.6m-NZ$4,073,109.0035.4x-122.6x3x
Sun, 23 Jul 2023NZ$519.7mNZ$167.6m-NZ$4,073,109.0036.4x-127.6x3.1x
Tue, 20 Jun 2023NZ$514.4mNZ$167.6m-NZ$4,073,109.0034.4x-126.3x3.1x
Thu, 18 May 2023NZ$465.4mNZ$150.7mNZ$1.1m20.9x430.1x3.1x
Sat, 15 Apr 2023NZ$470.9mNZ$150.7mNZ$1.1m20.9x435.2x3.1x
Mon, 13 Mar 2023NZ$502.4mNZ$150.7mNZ$1.1m22.2x459.4x3.3x
Wed, 08 Feb 2023NZ$516.7mNZ$153.3mNZ$1.2m23.4x427.4x3.4x
Fri, 06 Jan 2023NZ$515.1mNZ$153.3mNZ$1.2m23x426x3.4x
Sun, 04 Dec 2022NZ$514.6mNZ$153.3mNZ$1.2m22.7x425.7x3.4x
Tue, 01 Nov 2022NZ$516.3mNZ$143.0mNZ$3.9m19.6x132.7x3.6x
Thu, 29 Sep 2022NZ$492.5mNZ$143.0mNZ$3.9m17.9x126.6x3.4x
Sat, 27 Aug 2022NZ$506.1mNZ$142.3mNZ$8.0m18x63.4x3.6x
Price to Earnings Ratio

63.4x


Total Market Cap: NZ$506.1mTotal Earnings: NZ$8.0mTotal Revenue: NZ$142.3mTotal Market Cap vs Earnings and Revenue0%0%0%
New Zealand Pharma Industry Price to Earnings3Y Average 35.4x202320242025
Current Industry PE
    There are only 3 companies in the New Zealander Pharmaceuticals industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have remained mostly flat over the last three years.
  • Meanwhile revenues for these companies have grown 16% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.

Industry Trends

Which industries have driven the changes within the New Zealand Healthcare industry?

NZ Market1.13%
Healthcare0.41%
Pharma-1.90%
Pharma-1.90%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
RUA Rua BioscienceNZ$0.0528.3%
+NZ$901.4k		15.6%PS11x

Latest News

RUA
NZ$0.052
Rua Bioscience
7D
8.3%
1Y
15.6%
AFT
NZ$2.60
AFT Pharmaceuticals
7D
-0.8%
1Y
-16.9%

We Think Shareholders May Want To Consider A Review Of AFT Pharmaceuticals Limited's (NZSE:AFT) CEO Compensation Package

Jul 25
We Think Shareholders May Want To Consider A Review Of AFT Pharmaceuticals Limited's (NZSE:AFT) CEO Compensation Package